Hyundai Bioscience Seeks Approval for Six More Months of Treatment After First Prostate Cancer Trial Patient Completes Initial Dosing
AI 요약 정보
- Hyundai Bioscience's first patient completes 12-week dosing
- Physician seeks approval for 180 more days of Pinitrium
- Treatment request does not establish efficacy; approval pending